Monoclonal Antibody Pharmacokinetics in Cynomolgus Monkeys Following Subcutaneous Administration: Physiologically Based Model Predictions from Physiochemical Properties

AbstractAn integrated physiologically based modeling framework is presented for predicting pharmacokinetics and bioavailability of subcutaneously administered monoclonal antibodies in cynomolgus monkeys, based onin silico structure-derived metrics characterizing antibody size, overall charge, local charge, and hydrophobicity. The model accounts for antibody-specific differences in pinocytosis, transcapillary transport, local lymphatic uptake, and pre-systemic degradation at the subcutaneous injection site and reliably predicts the pharmacokinetics of five different wild-type mAbs and their Fc variants following intravenous and subcutaneous administration. Significant associations were found between subcutaneous injection site degradation rate and the antibody ’s local positive charge of its complementarity-determining region (R = 0.56,p = 0.0012), antibody pinocytosis rate and its overall positive charge (R = 0.59,p = 0.00063), and antibody paracellular transport and its overall charge together with hydrophobicity (R = 0.63,p = 0.00096). Based on these results, population simulations were performed to predict the relationship between bioavailability and antibody local positive charge. In addition, model simulations were conducted to calculate the relative contribution of absorption pathways (lymphatic and blood), pr e-systemic degradation pathways (interstitial and lysosomal), and the influence of injection site lymph flow on antibody bioavailability...
Source: The AAPS Journal - Category: Drugs & Pharmacology Source Type: research